ConductScience.org, home

Paper6137366

Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.

Lund-Johansen P. Eur Heart J, 1983. Cited by 75 papers, by iCite.

Cite this record

ConductScience Library. Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol. Papers, record 6137366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6137366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.
PubMed
Journal
Eur Heart J
PubMed
Year
1983
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
75
iCite
Relative citation ratio, by iCite
4.77
iCite
Revised in PubMed
2019-05-11
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lund-Johansen PP

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AntagonistsMajor topic
HypertensionMajor topic
Alprenolol
Atenolol
Hemodynamics
Humans
Metoprolol
Pindolol
Propanolamines
Time Factors
Timolol

Source PubMed

Download CSV of topics

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 75 citations.

PMIDTitleJournalYearIn PapersSource
8776008The use of ratings of perceived exertion for exercise prescription in patients receiving beta-blocker therapy.Sports Med1996https://conductscience.org/library/papers/8776008PubMed
8395198
Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
Cardiovasc Drugs Ther1993https://conductscience.org/library/papers/8395198PubMed
8097925
Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.
Cardiovasc Drugs Ther1993https://conductscience.org/library/papers/8097925PubMed
6151890Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.Drugs1984https://conductscience.org/library/papers/6151890PubMed
3095111The effect of verapamil on cardiovascular and metabolic responses to exercise.Eur J Appl Physiol Occup Physiol1986https://conductscience.org/library/papers/3095111PubMed
2940080Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.Drugs1986https://conductscience.org/library/papers/2940080PubMed
2939867Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise.Br J Clin Pharmacol1986https://conductscience.org/library/papers/2939867PubMed
2897710Beta-adrenoceptor blockade and exercise. An update.Sports Med1988https://conductscience.org/library/papers/2897710PubMed
2567670Responses of glomerular filtration, renal blood flow and salt-water handling to acute cardioselective and non-selective beta-adrenoceptor blockade in essential hypertension.Eur J Clin Pharmacol1989https://conductscience.org/library/papers/2567670PubMed
2488103Acute and long-term hemodynamic effects of tiapamil at rest and during exercise in essential hypertension.Cardiovasc Drugs Ther1989https://conductscience.org/library/papers/2488103PubMed
2076384Hemodynamic effects of pindolol and atenolol at rest and during isometric exercise: a noninvasive study with healthy volunteers.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/2076384PubMed
1976342Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?Br J Clin Pharmacol1990https://conductscience.org/library/papers/1976342PubMed
1974512The role of multiple action agents in hypertension.Eur J Clin Pharmacol1990https://conductscience.org/library/papers/1974512PubMed
1678963
Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect.
Cardiovasc Drugs Ther1991https://conductscience.org/library/papers/1678963PubMed
1355664Comparison of ketanserin and celiprolol on regression of left ventricular hypertrophy in older hypertensive patients.Cardiovasc Drugs Ther1992https://conductscience.org/library/papers/1355664PubMed
1350486Long-term hemodynamic effects of antihypertensive treatment.Clin Investig1992https://conductscience.org/library/papers/1350486PubMed
1350480Pharmacological profile of beta-adrenoceptor blockers with vasodilating properties, especially carvedilol--rationale for clinical use.Clin Investig1992https://conductscience.org/library/papers/1350480PubMed
1290920
A comparison of the effects of the selective peripheral alpha 1-blocker terazosin with the selective beta 1-blocker atenolol on blood pressure, exercise performance and the lipid profile in mild-to-moderate essential hypertension.
Clin Auton Res1992https://conductscience.org/library/papers/1290920PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6137366

GET https://conductscience.org/api/papers/v1/6137366/authors